Signifor LAR-CH 60mg (Pasireotide Vials) 60mg

Signifor LAR-CH 60mg (pasireotide) is a long-acting injectable for hormone regulation. Used in pituitary disorders, it helps manage symptoms like excessive hormone production. Store between 2-8°C to maintain potency. Consult a healthcare provider for suitability.

Strength

60mg

Storage

2-8°

Manufacturer / TM Owner

Recordati Rare Diseases

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pasireotide, the active ingredient in Signifor LAR-CH 60mg, is used to treat conditions caused by pituitary tumors, such as Cushing's disease or acromegaly. It works by reducing the release of certain hormones that contribute to these conditions. This medication is designed for long-term use under medical supervision.

Side Effects

Signifor LAR-CH 60mg may help reduce symptoms like fatigue, swelling, or changes in facial features over time. Some users report improved energy levels and reduced discomfort associated with hormone imbalances. Individual responses vary, and effects may take several weeks to become noticeable.

Precautions & Warnings

Store Signifor LAR-CH 60mg vials between 2-8°C to preserve effectiveness. Keep the medication away from light and moisture. Always handle with clean hands and use sterile techniques when preparing the injection. Discard any unused portion as directed by a healthcare professional.

Avoid Interactions

Signifor LAR-CH 60mg may interact with medications that affect heart rhythm, such as certain antiarrhythmics or antidepressants. Caution is advised when combining it with drugs that influence blood sugar levels, including insulin or oral hypoglycemics. Alcohol and grapefruit products may also alter its effects.

Frequently Asked Questions

Signifor LAR-CH 60mg is used to treat pituitary-related conditions like Cushing's disease or acromegaly by reducing hormone overproduction.

It is administered as a long-acting injection, typically by a healthcare professional, every 28 days.

Common effects may include gastrointestinal discomfort, fatigue, or changes in blood sugar levels.

Pasireotide injections are available through licensed pharmacies with a valid prescription.

Store vials refrigerated between 2-8°C and protect from light until use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.